Biomarin Pharmaceutical Inc
NASDAQ:BMRN

Watchlist Manager
Biomarin Pharmaceutical Inc Logo
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Watchlist
Price: 52.87 USD -0.23% Market Closed
Market Cap: 10.2B USD

Wall Street
Price Targets

BMRN Price Targets Summary
Biomarin Pharmaceutical Inc

Wall Street analysts forecast BMRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BMRN is 92.97 USD with a low forecast of 55.55 USD and a high forecast of 128.1 USD.

Lowest
Price Target
55.55 USD
5% Upside
Average
Price Target
92.97 USD
76% Upside
Highest
Price Target
128.1 USD
142% Upside
Biomarin Pharmaceutical Inc Competitors:
Price Targets
BIIB
Biogen Inc
4% Upside
VNDA
Vanda Pharmaceuticals Inc
89% Upside
XGN
Exagen Inc
120% Upside
LTRN
Lantern Pharma Inc.
454% Upside
006280
Green Cross Corp
19% Upside
9926
Akeso Inc
40% Upside
FDMT
4D Molecular Therapeutics Inc
200% Upside
ALT
Altimmune Inc
254% Upside

Revenue
Forecast

Revenue Estimate
Biomarin Pharmaceutical Inc

For the last 13 years the compound annual growth rate for Biomarin Pharmaceutical Inc's revenue is 15%. The projected CAGR for the next 3 years is 9%.

15%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biomarin Pharmaceutical Inc

The compound annual growth rate of Biomarin Pharmaceutical Inc's operating income for the next 3 years is 28%.

N/A
Past Growth
28%
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
Biomarin Pharmaceutical Inc

The compound annual growth rate of Biomarin Pharmaceutical Inc's net income for the next 3 years is 33%.

N/A
Past Growth
33%
Estimated Growth
Estimates Accuracy
-13%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BMRN's stock price target?
Price Target
92.97 USD

According to Wall Street analysts, the average 1-year price target for BMRN is 92.97 USD with a low forecast of 55.55 USD and a high forecast of 128.1 USD.

What is Biomarin Pharmaceutical Inc's Revenue forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for Biomarin Pharmaceutical Inc's revenue is 15%. The projected CAGR for the next 3 years is 9%.

What is Biomarin Pharmaceutical Inc's Operating Income forecast?
Projected CAGR
28%

The compound annual growth rate of Biomarin Pharmaceutical Inc's operating income for the next 3 years is 28%.

What is Biomarin Pharmaceutical Inc's Net Income forecast?
Projected CAGR
33%

The compound annual growth rate of Biomarin Pharmaceutical Inc's net income for the next 3 years is 33%.

Back to Top